The clinical characteristics of new daily persistent headache.

The clinical characteristics of new daily persistent headache. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The clinical characteristics of new daily persistent headache. Abstract Text:

D Li,T D Rozen,

New daily persistent headache (NDPH) is a subtype of chronic daily headache. The literature on NDPH is scant and its true aetiology is unknown. A retrospective chart review was carried out from a computerized database at the Jefferson Headache Centre from August 1997 to May 2000 to identify patients with NDPH using the Silberstein et al. criteria. Forty women and 16 men were identified. Age of onset ranged from 12 to 78 years. The peak age of onset was the second and third decade in women and the fifth decade in men. Eighty-two per cent of patients were able to pinpoint the exact day their headache started. Onset occurred in relation to an infection or flu-like illness in 30%. A prior headache history was found in 38% of patients. A family history of headache was documented in 29%. The duration of daily headache ranged from 1.5 h to 24 h; 79% were continuous. Nausea occurred in 68% of patients, photophobia in 66%, phonophobia in 61%, and lightheadedness in 55%. Laboratory testing and neuroimaging in all patients was normal except for Epstein-Barr virus antibody titres, which were positive in 71% of seven patients tested, representing past infection. NDPH appears to be a female-predominant disorder, marked by a continuous daily headache with associated migrainous symptoms. Over 80% of patients could state the exact date their headache began. One-third of patients developed NDPH with a flu-like illness.

The clinical characteristics of new daily persistent headache. Publishing Authors By Initials

D Li,TD Rozen,

For similar investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: epidemiologic studies: case-control studies: retrospective studies research abstracts see: investigative techniques: epidemiologic methods: epidemiologic study characteristics as topic: epidemiologic studies: case-control studies: retrospective studies research

PUBMED ID PMID:

MEDLINE DATE:

The clinical characteristics of new daily persistent headache. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cephalalgia : an international journal of headache

VOLUME: 22

Page Numbers: 66-9

Journal Abbreviation: Cephalalgia

ISSN: 0333-1024

DAY: 11

MONTH: Feb

YEAR: 2002

The clinical characteristics of new daily persistent headache. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8200710

The clinical characteristics of new daily persistent headache. Keywords Mesh Terms:

KEYWORDS: Retrospective Studies

MESH TERMS: epidemiology

Chemical & Substance for Abstract: The clinical characteristics of new daily persistent headache. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The clinical characteristics of new daily persistent headache.

AFFILIATION: Jefferson Headache Center/Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cephalalgia

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The clinical characteristics of new daily persistent headache Related Publications

• Acroangiodermatitis.
• Atypical presentations of cluster headache.
• Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia.
• Clomiphene citrate for treatment refractory chronic cluster headache.
• Common variant in betaine-homocysteine methyltransferase (BHMT) and risk for spina bifida.
• Constructing the OCF2O Moiety Using BrF3.
• Endoplasmic Reticulum Stress Increases the Expression of Methylenetetrahydrofolate Reductase through the IRE1 Transducer.
• Genetic and nutritional deficiencies in folate metabolism influence tumorigenicity in Apcmin/+ mice.
• Hemicrania continua with aura.
• Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-{kappa}B/iNOS.
• Interview.
• Lipoid hepatitis and dermatitis vegetans(?).
• Mefolinate (5-methyltetrahydrofolate), but not folic acid, decreases mortality in an animal model of severe methylenetetrahydrofolate reductase deficiency.
• Melatonin in the preventive treatment of chronic cluster headache.
• Melkersson-Rosenthal syndrome presenting as a new daily persistent headache: relief with dapsone.
• Methylenetetrahydrofolate reductase (MTHFR): a novel target for cancer therapy.
• Modular headache theory.
• Non-hypothalamic cluster headache: the role of the greater occipital nerve in cluster headache pathogenesis.
• Polymorphisms in methionine synthase reductase and betaine-homocysteine S-methyltransferase genes: risk of placental abruption.
• Strain differences in mice highlight the role of DNA damage in neoplasia induced by low dietary folate.
• The clinical characteristics of new daily persistent headache.
• Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.
• Verapamil-responsive hemicrania continua in a patient with episodic cluster headache.
• [Acute compartment syndrome in the thigh]
• [Effect of several endocrine factors on the concentration of specific estrogen-binding protein in rat liver]
• [Effect of thyroid hormones on the complexing of hydrocortisone with transcortin in gonadectomized guinea pigs]
• [Multi-component system of proteins binding estradiol in rat liver cytosol. Relationship to sex steroids]
• [Multicomponent system of estrogen-binding proteins of liver cytosol: species differences in rats, mice and guinea pigs]
• [Nuclear estradiol receptors in several "non-target" organs of rats]
• [ON THE FUNCTIONAL STATE OF THE ADRENAL CORTEX IN EXPERIMENTAL MODELS OF RHEUMATISM.]